ESR1 and breast cancer: Additionally, in a previous study on PONV in breast cancer patients, Bakshi SG et al. reported that the incidence of PONV is higher for patients below 50 years of age and that there is a positive association between estrogen receptor positivity and PONV in patients above 50 years of age, which may be attributed to the altered hormonal milieu in these patients [25].